GeoVax Labs, Inc. (GOVX)
NASDAQ: GOVX · Real-Time Price · USD
1.530
-0.030 (-1.92%)
At close: Feb 20, 2026, 4:00 PM EST
1.530
0.00 (0.00%)
After-hours: Feb 20, 2026, 4:00 PM EST
GeoVax Labs Market Cap
GeoVax Labs has a market cap or net worth of $3.99 million as of February 20, 2026. Its market cap has decreased by -75.69% in one year.
Market Cap
3.99M
Enterprise Value
-991.86K
1-Year Change
-75.69%
Ranking
Category
Stock Price
$1.53
Market Cap Chart
Since September 11, 2019, GeoVax Labs's market cap has increased from $239.88K to $3.99M, an increase of 1,563.70%. That is a compound annual growth rate of 54.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 19, 2026 | 4.10M | -44.23% |
| Dec 31, 2025 | 7.34M | -68.49% |
| Dec 31, 2024 | 23.31M | 141.85% |
| Dec 29, 2023 | 9.64M | -41.93% |
| Dec 30, 2022 | 16.60M | -28.16% |
| Dec 31, 2021 | 23.10M | 92.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 11, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Acurx Pharmaceuticals | 4.79M |
| PMGC Holdings | 4.65M |
| Cardio Diagnostics Holdings | 4.42M |
| Indaptus Therapeutics | 4.35M |
| Genprex | 4.13M |
| 60 Degrees Pharmaceuticals | 4.12M |
| Matinas BioPharma Holdings | 4.03M |
| Silo Pharma | 3.79M |